Discontinue if irritation, redness or itching occurs
Do not ingest, inject, reconstitute, or otherwise administer
This is problematic because muscle mass contributes to metabolic rate, functional capacity, and long-term health
[1] The authors framed the observed metabolic shifts as a direct effect on lipid handling in the model rather than appetite suppression
The peptide did not produce adverse metabolic effects associated with full-length growth hormone, including insulin resistance, glucose intolerance, or IGF-1 elevation
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Small-molecule NNMT inhibitor often discussed with metabolic protocols